Canaccord Genuity Group Increases Hims & Hers Health (NYSE:HIMS) Price Target to $68.00

Hims & Hers Health (NYSE:HIMS) had its price objective boosted by equities researchers at Canaccord Genuity Group from $38.00 to $68.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective suggests a potential upside of 1.35% from the stock’s current price.

HIMS has been the topic of a number of other research reports. BTIG Research initiated coverage on Hims & Hers Health in a research report on Tuesday, January 7th. They set a “buy” rating and a $35.00 price target on the stock. Piper Sandler boosted their price target on Hims & Hers Health from $21.00 to $24.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. Bank of America downgraded Hims & Hers Health from a “buy” rating to an “underperform” rating and lowered their price target for the stock from $32.00 to $18.00 in a research report on Thursday, November 14th. TD Cowen reissued a “buy” rating and set a $28.00 price target on shares of Hims & Hers Health in a research report on Wednesday, November 20th. Finally, Citigroup downgraded Hims & Hers Health from a “neutral” rating to a “sell” rating and boosted their price target for the stock from $24.00 to $25.00 in a research report on Friday, January 10th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $28.33.

Hims & Hers Health Stock Up 14.7 %

Shares of NYSE:HIMS traded up $8.59 during midday trading on Wednesday, reaching $67.09. The company had a trading volume of 16,455,857 shares, compared to its average volume of 13,852,332. The business’s 50 day moving average price is $33.17 and its 200 day moving average price is $24.89. The stock has a market cap of $14.66 billion, a PE ratio of 152.53 and a beta of 1.35. Hims & Hers Health has a 1-year low of $9.22 and a 1-year high of $70.50.

Insider Buying and Selling

In other Hims & Hers Health news, CEO Andrew Dudum sold 33,513 shares of the firm’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $33.38, for a total value of $1,118,663.94. Following the sale, the chief executive officer now owns 33,502 shares of the company’s stock, valued at approximately $1,118,296.76. This trade represents a 50.01 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Melissa Baird sold 67,687 shares of the firm’s stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of $44.71, for a total value of $3,026,285.77. Following the completion of the sale, the chief operating officer now directly owns 706,872 shares in the company, valued at approximately $31,604,247.12. This represents a 8.74 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,052,332 shares of company stock valued at $32,620,497 over the last 90 days. 17.71% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of HIMS. CWM LLC lifted its stake in shares of Hims & Hers Health by 21.4% in the 3rd quarter. CWM LLC now owns 5,982 shares of the company’s stock valued at $110,000 after acquiring an additional 1,054 shares during the last quarter. Creative Planning lifted its stake in shares of Hims & Hers Health by 18.1% in the 3rd quarter. Creative Planning now owns 25,925 shares of the company’s stock valued at $478,000 after acquiring an additional 3,979 shares during the last quarter. Venture Visionary Partners LLC bought a new position in shares of Hims & Hers Health in the 3rd quarter valued at $238,000. Lake Street Private Wealth LLC lifted its stake in shares of Hims & Hers Health by 80.3% in the 3rd quarter. Lake Street Private Wealth LLC now owns 103,447 shares of the company’s stock valued at $1,905,000 after acquiring an additional 46,076 shares during the last quarter. Finally, International Assets Investment Management LLC bought a new position in shares of Hims & Hers Health in the 3rd quarter valued at $6,790,000. 63.52% of the stock is currently owned by institutional investors.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.